Developing Lung Cancer Screening in Hodgkin Lymphoma Survivors: a Qualitative Study
Completed
- Conditions
- Hodgkin Lymphoma
- Registration Number
- NCT04396119
- Lead Sponsor
- The Christie NHS Foundation Trust
- Brief Summary
To explore the topic of lung cancer screening following treatment for Hodgkin lymphoma from the perspective of survivors
- Detailed Description
Explore survivors' attitudes towards lung cancer and lung cancer screening Explore survivors' understanding of cancer screening as a concept and the benefits of screening and early detection Explore survivors' level of awareness of and attitudes towards their lung cancer risk Explore survivors' views on the barriers and motivating factors that would impact their decision to attend a lung cancer screening test
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- Details held in the ADAPT database at The Christie NHS Foundation trust
- Responded to most recent ADAPT study questionnaire (April - August 2019)
- Aged 18-80
- Previously treated for Hodgkin lymphoma without evidence of relapse for at least 5 years
- Able to provide informed consent
- Treated with radiotherapy (with lung tissue in the radiotherapy field) and/or alkylating agent containing chemotherapy.
Exclusion Criteria
- Previous or current diagnosis of lung cancer
- Stated within 2019 health questionnaire that they did not wish to be contacted
- Have participated in lung cancer screening through the Manchester Lung Health Checks
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Explore survivors' attitudes towards lung cancer and lung cancer screening 6 months Semi-structured interviews
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Christie NHS Foundation Trust
🇬🇧Manchester, United Kingdom